Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 253
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Pα+ Psychedelic Bulletin #233: FDA Floats Ibogaine Trial Design; Compass Talks Pricing; Potential LSD, Psilocybin Brand Names
Kenneth Tupper, PhD: Harm Reduction, Drug Education, Canadian Ayahuasca, and Psychedelic Public Health
Weekly Psychedelic Policy Briefing: October 5, 2026
Podcast: Oregon Backtracks on Fee Hike, California Funds Psychedelic Research, DEA Moves to Schedule 5 Tryptamines
Psychedelic Churches Need Psychedelic Seminaries
MindMed Announces Collaboration With Forian To Advance Development Of Personalized Psychiatry...
Navigating Psychedelics for Clinicians and Therapists – Q+A
Psychedelic Bulletin: Beckley Psytech Raises $80m in Series B; Bright Minds...
PTSF73 – Origin Stories, Complexity, and Transpersonal Psychology
Exploring the Role of Serotonin 2A Activation in LSD’s Effects on...
Cybin Files Two Additional International Patent Applications in Support of the...
Wesana Health Highlights Recent Appointments to Board of Directors
Tryp Therapeutics Appoints Dennis Langer, M.D., J.D. as Senior Advisor
Bright Minds Biosciences (“BMB”) Proprietary 5-HT2C Agonist Shows Significant Reduction in...
Mydecine Innovations Group signs five-year Master Collaboration Research Agreement with Johns...
Load more